The Female Health Company to Host First Quarter Conference Call on Friday,
February 4, 2011
CHICAGO, Jan. 26, 2011 /PRNewswire via COMTEX/ -- The Female Health Company
(FHCO) today announced that it will host an investor conference call to discuss
its operating results for the first quarter of FY2011 on Friday, February 4, 2011
at 11:00 a.m. Eastern Time (EST). The Company expects to report its operating
results earlier the same day.
Shareholders and other interested parties may participate in the conference call
by dialing 1-877-317-6789 (international participants dial 1-412-317-6789) and
asking to be connected to "The Female Health Company Conference Call" a few
minutes before 11:00 a.m. EST on February 4, 2011. A replay of the call will be
available one hour after the call through 9:00 a.m. EST on Friday, February 18,
2011 by dialing 1-877-344-7529 (international callers dial 1-412-317-0088) and
entering the conference ID 447806.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets
the FC2 Female Condom(R) (FC2), which is available in the U.S. and about 100
other countries around the world. The Company owns certain worldwide rights to
the FC2 Female Condom(R), including patents that have been issued in the U.S.,
Europe, Canada, Australia, South Africa, Japan, China, Spain, Mexico, Greece and
Turkey and are pending in various countries. The FC2 Female Condom(R) is the only
available FDA-approved product controlled by a woman that offers dual protection
against sexually transmitted diseases, including HIV/AIDS, and unintended
pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by
U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995:
The statements in this release which are not historical facts are forward-looking
statements based upon the Company's current plans and strategies, and reflect the
Company's current assessment of the risks and uncertainties related to its
business, including such things as product demand and market acceptance; the
economic and business environment and the impact of government pressures;
currency risks; capacity; efficiency and supply constraints; and other risks
detailed in the Company's press releases, shareholder communications and
Securities and Exchange Commission filings. Actual events affecting the Company
and the impact of such events on the Company's operations may vary from those
currently anticipated.
For more information about the Female Health Company visit the Company's website
at femalehealth.com and femalecondom.org. If you would like
to be added to the Company's e-mail alert list, please send an e-mail to
FHCInvestor@femalehealthcompany.com.
SOURCE The Female Health Company |
